Toshiba protocols correct artifacts
Toshiba America Medical Systems of Tustin, CA, will demonstrateprogress at the Society of Nuclear Medicine meeting in its approachto dealing with two artifact phenomena: photon scatter and attenuation.While competitors have concentrated on the
Toshiba America Medical Systems of Tustin, CA, will demonstrateprogress at the Society of Nuclear Medicine meeting in its approachto dealing with two artifact phenomena: photon scatter and attenuation.While competitors have concentrated on the attenuation correctioncomponent of artifact correction, Toshiba has emphasized TripleEnergy Window (TEW), a scatter correction technique essentialto effective dual-energy imaging, according to Steve Sickels,director of the vendor's nuclear medicine business unit.
Research has shown that scatter correction and attenuationcorrection are both needed for optimal imaging, he said. Toshibawill feature clinical studies performed at Harper-Grace Hospitalin Detroit and Keio University in Tokyo that demonstrate TEW'sdual thallium/sestamibi imaging capabilities. An application for510(k) clearance was filed in April for TEW, which operates onToshiba's GCA-7200A/DI dual-head or GCA-7100A/DI single-head cameras.
Progress on the scatter correction front has cleared the wayfor the introduction of TransView, Toshiba's investigational attenuationcorrection technique (SCAN 6/7/95), Sickels said. The device,designed for the GCA-7200A, uses a refillable flood that attachesto a detector. Users may choose among several transmission sources,including technetium, cobalt-57, and gadolinium. Toshiba willalso feature a new line of inexpensive processing and displayworkstations based on Sun's SparcStation 4 platform, Sickles said.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
